Effect of Rotavirus Vaccination on Death From Childhood Diarrhea in Mexico
This article, published in The New England Journal of Medicine, discusses a study on the effectiveness of rotavirus vaccine in Mexico. The study examined the impact of vaccination on diarrheal deaths in Mexican children between 2008 and 2009 following a phased introduction of the orally administered Rotarix™, manufactured by GlaxoSmithKline Biologicals. In the 2009 rotavirus season, diarrheal disease death rates dropped by more than 65 percent among children age two and under. The study concluded that after the introduction of a rotavirus vaccine, a significant decline in diarrhea-related deaths among Mexican children was observed, which suggests a potential benefit from rotavirus vaccination.
Author(s): Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al.
Visit web page (English)
(Located at content.nejm.org)
Citation: Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al. Effect of Rotavirus Vaccination on Death From Childhood Diarrhea in Mexico. New England Journal of Medicine. 2010;362(4):299-305.